| __timestamp | Jazz Pharmaceuticals plc | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 1055457000 | 116287000 |
| Thursday, January 1, 2015 | 1222277000 | 136004000 |
| Friday, January 1, 2016 | 1382587000 | 203017000 |
| Sunday, January 1, 2017 | 1508505000 | 287023000 |
| Monday, January 1, 2018 | 1769378000 | 393541000 |
| Tuesday, January 1, 2019 | 2033831000 | 376095000 |
| Wednesday, January 1, 2020 | 2214650000 | 467938000 |
| Friday, January 1, 2021 | 2653478000 | 504714000 |
| Saturday, January 1, 2022 | 3118857000 | 580017000 |
| Sunday, January 1, 2023 | 3398627000 | 523742000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, gross profit is a key indicator of a company's financial health and market prowess. From 2014 to 2023, Jazz Pharmaceuticals plc has consistently outperformed Supernus Pharmaceuticals, Inc. in generating gross profit. Jazz's gross profit surged by over 220% during this period, peaking in 2023 with a remarkable $3.4 billion. In contrast, Supernus, while showing steady growth, reached a maximum of $580 million in 2022, marking a 400% increase from its 2014 figures. This stark difference highlights Jazz's dominant market position and strategic advantage. The data underscores the importance of innovation and market strategy in the pharmaceutical industry, where Jazz has clearly excelled. As the industry evolves, these insights provide a glimpse into the financial dynamics shaping the future of healthcare.
Key Insights on Gross Profit: Eli Lilly and Company vs Jazz Pharmaceuticals plc
Gross Profit Trends Compared: Sanofi vs Jazz Pharmaceuticals plc
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Gross Profit Comparison: Teva Pharmaceutical Industries Limited and Jazz Pharmaceuticals plc Trends
Gross Profit Trends Compared: Catalent, Inc. vs Supernus Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Jazz Pharmaceuticals plc and Veracyte, Inc. Trends
Analyzing Cost of Revenue: Jazz Pharmaceuticals plc and Supernus Pharmaceuticals, Inc.
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Comparison: Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. Trends
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.